Kenvue · ISIN: US49177J1025

Kenvue Increases Quarterly Cash Dividend

Kenvue Inc. (NYSE: KVUE) today announced its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock, which represents a 1.2 percent increase compared to the prior quarterly dividend. The quarterly dividend is payable on August 27, 2025, to shareholders of record as of the close of business on August 13, 2025. A...

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

This news feed is a compilation of company-relevant news from the most popular and widest-reaching newswire services. The feed is updated several times. For market-related publications, we recommend the X-Billboard, the Daily News Digest or our Premium Information Service.
Most recent update: 30.07.2025 | 12:45
30 July 2025 12:45PM
Kenvue Increases Quarterly Cash Dividend
Kenvue Inc. (NYSE: KVUE) today announced its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock, which represents a 1.2 percent increase compared to the prior quarterly dividend. The quarterly dividend is payable on August 27, 2025, to shareholders of record as of the close of business on August 13, 2025. A...
Kenvue
© BusinessWire
25 July 2025 12:45PM
Kenvue to Announce Second Quarter 2025 Results on August 7, 2025
Kenvue Inc. (NYSE: KVUE) will announce its second quarter 2025 financial results before the market opens on August 7, 2025. The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international...
Kenvue
© BusinessWire
14 July 2025 12:45PM
Kenvue Announces CEO Transition and Actions to Unlock Shareholder Value
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company to unlock shareholder value and reach its full potential. The Board has made a Chief Executive Officer transition and is advancing an ongoing comprehensive review of strategic alternatives. This press release features multim...
Kenvue
© BusinessWire
02 June 2025 12:15PM
Kenvue Debuts on Fortune 500 List
Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced it has made the prestigious Fortune 500 list for the first time since becoming a fully independent company. With 2024 full year sales of $15.5 billion, Kenvue is listed at number 281. The company’s debut is a testament to the powe...
Kenvue
© BusinessWire
21 May 2025 12:45PM
Kenvue Announces Participation in Deutsche Bank's dbAccess Global Consumer Conference
Kenvue Inc. (NYSE: KVUE), the maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol®, today announced the Company’s participation in Deutsche Bank’s dbAccess Global Consumer Conference in Paris, France. Thibaut Mongon, Chief Executive Officer, Amit Banati, Chief Financial Officer, and Carlton Lawson, Group President, Europe,...
Kenvue
© BusinessWire
14 May 2025 12:45PM
Everyday Care in Action: Thousands of Kenvue Employees Come Together Across 21 Markets to Help Advance Healthier Communities
Kenvue Inc. (NYSE: KVUE), the maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol®, today announced its global community engagement efforts in celebration of Kenvue Cares Week, the company’s signature annual volunteer initiative part of its Healthy Lives Mission. Kenvue Cares Week is a testament to the strong Kenvue commit...
Kenvue
© BusinessWire
08 May 2025 12:50PM
Kenvue Reports First Quarter 2025 Results
Kenvue Inc. (NYSE: KVUE) today announced financial results for the first quarter ended March 30, 2025. “In Q1, our teams executed our plans while continuing to navigate an evolving macro and consumer environment,” said Thibaut Mongon, Chief Executive Officer. “We are committed and focused on activating our brands while staying agile and flexible...
Kenvue
© BusinessWire
24 April 2025 12:45PM
Kenvue to Announce First Quarter 2025 Results on May 8, 2025
Kenvue Inc. (NYSE: KVUE) will announce its first quarter 2025 financial results before market open on May 8, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations...
Kenvue
© BusinessWire
16 April 2025 02:19PM
Kenvue Declares Quarterly Cash Dividend
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on its common stock. This quarterly dividend is payable on May 28, 2025, to shareholders of record as of the close of business on May 14, 2025. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company...
Kenvue
© BusinessWire
16 April 2025 12:45PM
Kenvue Announces 5-Year Collaboration with Microsoft to Transform Digital Operations
Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong foundation for transforming digital operations through advanced Artificial Intelligence (AI) technologies. These technologies include machine-enabled collab...
Kenvue
© BusinessWire
07 April 2025 12:45PM
OGX® Haircare Introduces Shay Mitchell as First Global Brand Ambassador
New campaign introduces new Bond Protein Repair hair line designed to deliver effective bonding repair – at a fraction of the price of prestige brands  SUMMIT, N.J., April 7, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) announces actress and entrepreneur, Shay Mitchell, as the global brand ambassador for OGX®, stepping in as the face of the bran...
Kenvue
© PR Newswire
31 March 2025 12:45PM
Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign
The Brand's Latest Mineral Sunscreen AddressesTop Consumer Barriers to Daily Sunscreen Use SUMMIT, N.J., March 31, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® Ultra Sheer ® Face Liquid Mineral Sunscreen SPF 70. A December 2024 Kenvue research stud...
Kenvue
© PR Newswire
31 March 2025 12:45PM
Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign
The Brand's Latest Mineral Sunscreen AddressesTop Consumer Barriers to Daily Sunscreen Use SUMMIT, N.J., March 31, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® Ultra Sheer ® Face Liquid Mineral Sunscreen SPF 70. A December 2024 Kenvue research stud...
Kenvue
© PR Newswire
31 March 2025 12:45PM
Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign
The Brand's Latest Mineral Sunscreen AddressesTop Consumer Barriers to Daily Sunscreen Use SUMMIT, N.J., March 31, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® Ultra Sheer ® Face Liquid Mineral Sunscreen SPF 70. A December 2024 Kenvue research stud...
Kenvue
© PR Newswire
31 March 2025 12:45PM
Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign
The Brand's Latest Mineral Sunscreen AddressesTop Consumer Barriers to Daily Sunscreen Use SUMMIT, N.J., March 31, 2025 /CNW/ -- Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® Ultra Sheer ® Face Liquid Mineral Sunscreen SPF 70. A December 2024 Kenvue research study found...
Kenvue
© PR Newswire
31 March 2025 12:45PM
Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign
The Brand's Latest Mineral Sunscreen AddressesTop Consumer Barriers to Daily Sunscreen Use SUMMIT, N.J., March 31, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® Ultra Sheer ® Face Liquid Mineral Sunscreen SPF 70. A December 2024 Kenvue research stud...
Kenvue
© PR Newswire
19 March 2025 11:45AM
Kenvue Ribbon-Cutting Marks Official Opening of New Global Headquarters in Summit, New Jersey
Today, Kenvue Inc. (NYSE: KVUE) held a ribbon-cutting ceremony for its new 290,000 sq. ft. global headquarters in Summit, New Jersey. The Company – which marked the start of construction of its 100,000 sq. ft. state-of-the-art Science and Innovation Lab at a ceremony last year – has officially moved its headquarters from Skillman to Summit, New Je...
Kenvue
© BusinessWire
07 March 2025 10:05PM
Kenvue to Showcase New Clinical Data on Skin Longevity, Hydration and Sun Protection at American Academy of Dermatology Association Meeting
Kenvue Inc. (NYSE: KVUE) will share new clinical data demonstrating how its iconic brands are leveraging the latest science to shape the future of the Skin Health & Beauty category at the 2025 American Academy of Dermatology (AAD) Annual Meeting, set for March 7-11, 2025 at the Orlando Convention Center in Orlando, Florida. In findings from t...
Kenvue
© BusinessWire
05 March 2025 02:05PM
Kenvue Announces Three New Appointments to Board of Directors
Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sarah Hofstetter, President of Profitero, Ltd., and Erica Mann, former President and Head of Bayer’s Consumer Health Division, to the Company’s Board of Directors (the “Board”). Additionally,...
Kenvue
© BusinessWire
13 February 2025 12:45PM
Kenvue to Webcast Presentation at the Consumer Analyst Group of New York Conference
Kenvue Inc. (NYSE: KVUE) today announced Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will present at the Consumer Analyst Group of New York (CAGNY) Conference on Wednesday, February 19, 2025, at 3:00 p.m. Eastern Time. A live webcast of the presentation will be available...
Kenvue
© BusinessWire
06 February 2025 12:45PM
Kenvue Reports Full Year and Fourth Quarter 2024 Results
Kenvue Inc. (NYSE: KVUE), today announced financial results for the full year and fiscal fourth quarter ended December 29, 2024. “We delivered on our 2024 profit commitments despite headwinds that resulted in softer than expected sales growth and we enter 2025 as a more competitive company with stronger foundations,” said Thibaut Mongon, Chief E...
Kenvue
© BusinessWire
05 February 2025 04:39PM
Kenvue Highlights Commitment to Shareholder Value
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today issued the following statement in response to Starboard Value’s (“Starboard”) submission of four nominees to stand for election to the Kenvue Board of Directors at Kenvue’s 2025 Annual Meeting of Shareholders: The Kenvue Board and managem...
Kenvue
© BusinessWire
04 February 2025 10:05PM
Neutrogena® Introduces Tate McRae as Global Brand Ambassador
 On the Heels of its 10th Anniversary, the Brand's Iconic Hydro Boost Collection Is Revealing a Juicy, Fresh Take SKILLMAN, N.J., Feb. 4, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) announces global sensation Tate McRae as the newest face of Neutrogena®. This announcement marks the debut campaign under Neutrogena's bold new positioning, 'Beauty...
Kenvue
© PR Newswire
04 February 2025 10:05PM
Neutrogena® Introduces Tate McRae as Global Brand Ambassador
On the Heels of its 10th Anniversary, the Brand's Iconic Hydro Boost Collection Is Revealing a Juicy, Fresh Take SKILLMAN, N.J., Feb. 4, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) announces global sensation Tate McRae as the newest face of Neutrogena®. This announcement marks the debut campaign under Neutrogena's bold new positioning, 'Beauty...
Kenvue
© PR Newswire
04 February 2025 10:05PM
Neutrogena® Introduces Tate McRae as Global Brand Ambassador
 On the Heels of its 10th Anniversary, the Brand's Iconic Hydro Boost Collection Is Revealing a Juicy, Fresh Take SKILLMAN, N.J., Feb. 4, 2025 /CNW/ -- Kenvue Inc. (NYSE: KVUE) announces global sensation Tate McRae as the newest face of Neutrogena®. This announcement marks the debut campaign under Neutrogena's bold new positioning, 'Beauty to a S...
Kenvue
© PR Newswire
04 February 2025 10:05PM
Neutrogena® Introduces Tate McRae as Global Brand Ambassador
On the Heels of its 10th Anniversary, the Brand's Iconic Hydro Boost Collection Is Revealing a Juicy, Fresh Take SKILLMAN, N.J., Feb. 4, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) announces global sensation Tate McRae as the newest face of Neutrogena®. This announcement marks the debut campaign under Neutrogena's bold new positioning, 'Beauty...
Kenvue
© PR Newswire
04 February 2025 10:05PM
Neutrogena® Introduces Tate McRae as Global Brand Ambassador
On the Heels of its 10th Anniversary, the Brand's Iconic Hydro Boost Collection Is Revealing a Juicy, Fresh Take SKILLMAN, N.J., Feb. 5, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) announces global sensation Tate McRae as the newest face of Neutrogena®. This announcement marks the debut campaign under Neutrogena's bold new positioning, 'Beauty...
Kenvue
© PR Newswire
23 January 2025 12:45PM
Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025
Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from in...
Kenvue
© BusinessWire
16 January 2025 12:45PM
Kenvue Declares Quarterly Cash Dividend
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue’s common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025. About Kenvue Kenvue Inc. is the world’s largest pure-play consu...
Kenvue
© BusinessWire
25 November 2024 12:00PM
Kenvue Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company’s participation in the Morgan Stanley Global Consumer & Retail Conference in New York City. Thibaut Mongon, Chief Executive Officer and Paul Ruh, Chief Financial Officer will participate in a fireside chat on Wednesday, December 4, 2024, at 11:45 a.m. Eastern Time. A live webcast...
Kenvue
© BusinessWire
07 November 2024 12:45PM
Kenvue Reports Third Quarter 2024 Results
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), today announced financial results for the fiscal third quarter ended September 29, 2024. “During the third quarter, we continued to drive strong productivity and realize efficiency benefits from Our Vue Forward, which we are reinvesting behind our iconic brands to unleash the full potential of our business and...
Kenvue
© BusinessWire
05 November 2024 02:19AM
Kenvue Canada Expands Ontario Manufacturing Facility to Boost Production of Over-the-Counter Medicines
Guelph facility manufactures more than 100 different medications including Tylenol®, Motrin®, Benylin® and Sudafed® GUELPH, ON, Nov. 4, 2024 /CNW/ - Kenvue Canada Inc., a division of Kenvue Inc. (NYSE: KVUE) ("Kenvue"), the world's largest pure-play consumer health company by revenue and maker of iconic brands such as Tylenol®, Aveeno, Listerine®...
Kenvue
© PR Newswire
31 October 2024 09:15PM
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establishing multi-year partnerships with Dr. Dhaval Bhanusali, renowned skincare innovator, and Dr. Muneeb Shah, the most followed dermatologist worldwide...
Kenvue
© BusinessWire
18 October 2024 12:45PM
Kenvue to Announce Third Quarter 2024 Results on November 7, 2024
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will announce its third quarter 2024 financial results before market open on November 7, 2024. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by...
Kenvue
© BusinessWire
17 October 2024 12:45PM
Kenvue Declares Quarterly Cash Dividend
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue’s common stock. This quarterly dividend is payable on November 27, 2024, to shareholders of record as of the close of business on November...
Kenvue
© BusinessWire
23 September 2024 12:45PM
Kenvue Drives Climate Action Strategy Forward
Kenvue Inc. (NYSE: KVUE) (“Kenvue” or the “Company”), the maker of iconic brands such as Aveeno®, Listerine®, Neutrogena® and Tylenol®, is advancing progress toward the climate change goals outlined in its Healthy Lives Mission environmental, social and governance strategy, including releasing its first Task Force on Climate-related Financial Disc...
Kenvue
© BusinessWire
23 August 2024 12:45PM
Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company’s participation in the Barclays Global Consumer Staples Conference in Boston, Massachusetts. Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will participate in a fireside chat on Thursday, September 5, 2024, at...
Kenvue
© BusinessWire
15 August 2024 12:45PM
Kenvue Introduces Patented Micro-Peptide Technology with Neutrogena® Collagen Bank™ Launch
New Product Line Features Two Moisturizers Designed to Defend and Support the Skin's Natural Collagen SKILLMAN, N.J., Aug. 15, 2024 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) ("Kenvue" or the "Company"), the world's largest pure-play consumer health company by revenue, is launching Neutrogena®1 Collagen Bank™ featuring the Company's patented micro-...
Kenvue
© PR Newswire

The information service offers company-relevant news from leading newswire services in a compact form for a quick overview. When the detailed view is called up, further information can be accessed if required. The navigation elements in previewer mode allow you to quickly switch to the most frequently visited tool sections. From there, you can access further areas that can be used for your own research and analysis. Tip: The information platform now includes more than 50 mini-apps developed in-house.

AI First: Feel free to test the AI integration that will quickly put you on a par with financial journalists and research houses

Further information

The information presented in this section is secondary publications. The content corresponds to the source information. You can find information on the author of the news item in the detailed information of a publication. News relating to listed companies may have been created due to regulatory publication obligations, due to regular public relations work for PR or marketing reasons or by third parties against the background of investor information.

The combination of information and graphic elements contributes significantly to visual orientation and navigation through complex issues. This makes it easier to grasp, contextualize and process key content. Images, logos and other or comparable graphic and textual elements used on the information portal are used for visual navigation, are part of the original message or have illustrative purposes. All rights to these elements are held by the respective owners of the trademark or image rights. They are used without intent to infringe copyright or intellectual property rights. Image material provided via the distribution networks is treated as part of the original message and processed accordingly.

If you believe that copyright or intellectual property rights have been infringed by the presentation, please contact us immediately to clarify your concerns.